Key result
Bovine pulmonary visceral pleura bioprosthetic valves demonstrated suitable mechanical strength and showed no signs of calcification, thrombosis, inflammation, or fibrosis at four months in a swine model.
Why the study?
Bovine pericardium is common for bioprosthetic valves, but improved materials are needed for longer-term outcomes.
Does bovine pulmonary visceral pleura provide suitable mechanical strength and in vivo performance as bioprosthetic heart valve cusps in a swine model?
Does bovine pulmonary visceral pleura provide suitable mechanical strength and in vivo performance as bioprosthetic heart valve cusps in a swine model?
Bovine pulmonary visceral pleura demonstrates suitable mechanical strength and promising in vivo performance without calcification or thrombosis in a swine model, suggesting potential as a novel bioprosthetic valve material.
Answers are grounded in this paper and cite their sources.
Encourages further preclinical testing of bovine pleura valves; leaves open human translation pending durability and safety data.
Objective Bovine pericardium is common biological material for bioprosthetic heart valve. There remains a significant need, however, to improve bioprosthetic valves for longer-term outcomes. This study aims to evaluate the chronic performance of bovine pulmonary visceral pleura (PVP) as bioprosthetic valve cusps. Methods The PVP was extracted from the bovine lung and fixed in 0.625% glutaraldehyde overnight at room temperature. The PVP valve cusps for the bioprosthetic valve were tailored using a laser cutter. Three leaflets were sewn onto a nitinol stent. Six PVP bioprosthetic valves were loaded into the test chamber of the heart valve tester to complete 100 million cycles. Six other PVP bioprosthetic valves were transcardially implanted to replace pulmonary artery valve of six pigs. Fluoroscopy and intracardiac echocardiography were used for in vivo assessments. Thrombosis, calcification, inflammation, and fibrosis were evaluated in the terminal study. Histologic analyses were used for evaluations of any degradation or calcification. Results All PVP bioprosthetic valves completed 100 million cycles without significant damage or tears. In vivo assessments showed bioprosthetic valve cusps open and coaptation at four months post-implant. No calcification and thrombotic deposits, inflammation, and fibrosis were observed in the heart or pulmonary artery. The histologic analyses showed complete and compact elastin and collagen fibers in the PVP valve cusps. Calcification-specific stains showed no calcific deposit in the PVP valve cusps. Conclusions The accelerated wear test demonstrates suitable mechanical strength of PVP cusps for heart valve. The swine model demonstrates that the PVP valve cusps are promising for valve replacement.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2023) studied Pulmonary valve replacement (preclinical model) (n=6). Bovine pulmonary visceral pleura (PVP) bioprosthetic valve was evaluated on Valve durability, calcification, thrombosis, inflammation, and fibrosis at 4 months post-implant. Bovine pulmonary visceral pleura bioprosthetic valves demonstrated suitable mechanical strength and showed no signs of calcification, thrombosis, inflammation, or fibrosis at four months in a swine model.
Synapse has enriched 10 related papers. Consider them for comparative context: